Detalhe da pesquisa
1.
Longitudinal changes in global structural brain connectivity and cognitive performance in former hospitalized COVID-19 survivors: an exploratory study.
Exp Brain Res
; 241(3): 727-741, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708380
2.
Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trial.
HIV Med
; 14(7): 437-44, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480640
3.
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial.
HIV Med
; 14(1): 49-59, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23088336
4.
Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data.
Value Health
; 17(7): A664, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27202422